What is the appropriate dosage of Amoxi (amoxicillin) 400mg/5ml for a 37-pound pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin Dosing for a 37-Pound Pediatric Patient

For a 37-pound (16.8 kg) child, the appropriate dose of amoxicillin 400mg/5ml suspension is 6.3 mL twice daily (providing 50 mg/kg/day) for standard infections, or 11.3 mL twice daily (providing 90 mg/kg/day) for high-risk infections or suspected resistant organisms. 1, 2

Weight Conversion and Dose Calculation

  • 37 pounds = 16.8 kg
  • The 400mg/5ml suspension provides 80 mg/mL concentration 2

Standard-Dose Regimen (For Low-Risk Infections)

For mild to moderate infections without risk factors:

  • Dose: 25 mg/kg/dose every 12 hours 2
  • For this 16.8 kg child: 25 mg/kg × 16.8 kg = 420 mg per dose
  • Volume: 5.25 mL (approximately 5 mL) twice daily 2
  • Total daily dose: 50 mg/kg/day (840 mg/day)

This standard regimen is appropriate for children without recent antibiotic exposure, not attending daycare, and in communities with low prevalence of resistant Streptococcus pneumoniae (<10%). 3, 4

High-Dose Regimen (For High-Risk Infections)

For moderate to severe infections or children with risk factors, use high-dose amoxicillin:

  • Dose: 45 mg/kg/dose every 12 hours 2
  • For this 16.8 kg child: 45 mg/kg × 16.8 kg = 756 mg per dose
  • Volume: 9.5 mL twice daily 2
  • Total daily dose: 90 mg/kg/day (1,512 mg/day)

Risk Factors Requiring High-Dose Therapy

High-dose amoxicillin (80-90 mg/kg/day) is indicated when any of the following risk factors are present: 3, 1

  • Age younger than 2 years 1
  • Daycare attendance 3, 1
  • Recent antibiotic use within the previous 30 days 3, 1
  • Moderate to severe illness at presentation 3
  • Geographic area with high prevalence (>10%) of penicillin-resistant S. pneumoniae 3

When to Use Amoxicillin-Clavulanate Instead

Switch to amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate) if: 3, 1

  • Treatment failure after 48-72 hours on amoxicillin alone 1
  • Suspected β-lactamase-producing organisms (H. influenzae or M. catarrhalis) 3
  • Incomplete Haemophilus influenzae type b vaccination 1
  • Initial presentation with severe illness 1

Treatment Duration and Monitoring

  • Continue treatment for minimum 48-72 hours beyond symptom resolution 2
  • For Streptococcus pyogenes infections, treat for at least 10 days to prevent acute rheumatic fever 2
  • Most respiratory infections require 7-10 days of treatment 3, 5
  • Clinical improvement should be evident within 48-72 hours; if not, reassess the patient 1, 5

Critical Dosing Considerations

Common pitfalls to avoid:

  • Verify the suspension concentration before dispensing - this patient has 400mg/5ml (80 mg/mL), but other concentrations exist (125mg/5ml, 250mg/5ml) 1, 2
  • Underdosing leads to treatment failure and promotes antimicrobial resistance - standard 40 mg/kg/day dosing is inadequate for resistant organisms 6, 4
  • Administer at the start of meals to minimize gastrointestinal intolerance 2
  • Shake suspension well before each use 2
  • Discard unused suspension after 14 days; refrigeration is preferable but not required 2

Evidence Supporting Dosing Recommendations

The high-dose regimen (80-90 mg/kg/day) achieves middle ear fluid and sinus concentrations adequate to overcome penicillin-resistant S. pneumoniae with MICs up to 2-4 mg/L. 1, 6 Research demonstrates that standard 40 mg/kg/day dosing is inadequate, particularly during viral coinfection, which reduces antibiotic penetration into infected tissues. 6 The twice-daily dosing schedule improves adherence compared to three-times-daily regimens while maintaining comparable efficacy. 7, 8

Local prevalence data suggest that while nasopharyngeal carriage of nonsusceptible S. pneumoniae may be high (48% of isolates), the actual probability of infection with highly resistant strains requiring high-dose therapy is lower (3-7%). 4 However, given the consequences of treatment failure, high-dose therapy is warranted when risk factors are present. 3, 1

References

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.